Literature DB >> 21058213

A comparison of acute psychiatric care under Medicaid carve-outs, HMOs, and fee-for-service.

Christopher G Hudson1, Julia Chafets.   

Abstract

This study compares the use of acute psychiatric hospitalization; selected outcomes, including rehospitalization; as well as costs associated with the health maintenance organization (HMO), carve-out, and fee-for-service models as implemented in the Massachusetts Medicaid program between FY1994 and FY2000. This is a longitudinal analysis that primarily uses unduplicated individual data from the Massachusetts Case Mix database. Analyses focus on 56,518 individuals who were psychiatrically hospitalized on acute units within 57 hospitals. They employ Cox regression to compare rehospitalization among the three programs. The hypotheses were strongly supported: HMOs have the most substantial impacts in minimizing service provision, with the carve-out program having an impact intermediate between the HMO and fee-for-service programs. Lower utilization rates were associated with lower overall rates of hospitalization, shorter lengths of stay, fewer repeated stays, and less geographic access and greater displacement of psychiatric patients to medical units. The final model of rehospitalization has an overall predictive accuracy of 59.6%.

Entities:  

Mesh:

Year:  2010        PMID: 21058213     DOI: 10.1080/19371910903178821

Source DB:  PubMed          Journal:  Soc Work Public Health        ISSN: 1937-190X


  2 in total

1.  The impact of court-ordered psychiatric treatment on hospital length of stay: balancing legal and clinical concerns.

Authors:  Jinah Shin; Maria Chona P San Gabriel; Agnes Ho-Periola; Sheryl Ramer; Youngihn Kwon; Heejung Bang
Journal:  J Korean Acad Psychiatr Ment Health Nurs       Date:  2022-06-30

2.  The relationship between insurance and health outcomes of diabetes mellitus patients in Maryland: a retrospective archival record study.

Authors:  Soo-Hoon Lee; Samuel L Brown; Andrew A Bennett
Journal:  BMC Health Serv Res       Date:  2021-05-24       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.